Vice-President, IPA and Executive Vice-Chairperson, Cipla
Representing the third generation of Cipla’s founding family, Ms Samina Hamied is the Executive Vice-Chairperson of the Company. Samina is an MSc in International Accounting and Finance from the London School of Economics and Political Science.
She worked in the UK and the US with leading global firm Goldman Sachs before joining the Cipla leadership team in 2011.
In 2013, she was designated as “Head Strategic Projects – Cipla New Ventures”. She was appointed as an Executive Director of the Company in 2015 and elevated as the Executive Vice-Chairperson of the Company, in 2016. She has been instrumental in driving the Company’s current transformation agenda.
Ms Samina has played a key role in successfully incubating and shaping Cipla Health Limited, and spearheading Cipla’s ambitious foray into the US market with strategic acquisitions. She has built a top-class leadership pipeline for the Company as it continues to spread its wings globally.
She has been bestowed with multiple honours and awards. In 2017, she received the “Most Powerful Women in Business” award from Business Today. In 2018, Forbes named Ms Hamied to their list of top 25 emergent women business leaders in Asia. For 3 consecutive years – 2018, 2019 and 2020 – Fortune India named her among the most powerful women in business.
Cipla began its journey in 1935 with the purpose of making healthcare accessible to all. For over eight decades, it has dedicated itself not just to improving access to quality healthcare but to making a difference in the lives of people and in the process established an enviable international footprint.
Today Cipla is over USD 2.5 billion company, ranked 3rd largest in pharma in India. It is among the most dispensed generic players in the US. Cipla’s strengths in the respiratory, antiretroviral, urology, cardiology, anti-infective and CNS segments are well-known. Today, Cipla has 46 manufacturing sites around the world that produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to 80+ markets.